Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating the role of magnesium in cognitive function after stroke

Official title: Relationship Between Magnesium Concentration in Blood and Kognitive Functions After Stroke

Run by BDH-Klinik Hessisch Oldendorf · NCT05132517 · Data updated 2026-11-12

This study is trying to see if magnesium levels affect thinking skills in people who have had a stroke, by looking at their cognitive abilities during and after their hospital stay.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorBDH-Klinik Hessisch Oldendorf
Academic / other
Locations1 site (Hessisch Oldendorf, Lower Saxony)
StatusRecruiting
StartedOctober 26, 2022
Main results expectedDecember 31, 2026
Study endsSeptember 30, 2027
Registry record updatedApril 20, 2026
Trial IDNCT05132517 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who have experienced either ischemic or hemorrhagic strokes and can provide written consent.

Probably not a fit

Patients with pre-existing cognitive impairments, dementia, or significant mental disorders prior to the stroke may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between magnesium concentration and cognitive impairments in stroke patients. It will assess stroke severity and cognitive abilities using various scales during the initial hospital stay and follow-up assessments at 4 weeks and 3 months post-admission. The study will include both ischemic and hemorrhagic stroke patients, evaluating their magnesium levels and cognitive performance over time. Additionally, MRI scans will be conducted to measure the attention network of the patients.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cognitive impairments in stroke patients through magnesium supplementation.

How similar studies have gone: While the relationship between magnesium levels and cognitive function in stroke patients has not been extensively studied, similar investigations in other contexts have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ischemic/hemmorhagic stroke
* written consent form

Exclusion Criteria:

* pre-existing dementia or cognitive impairment before stroke onset
* pre-existing mental disorder (depression) or present/prior long-term treatment (\> 6 months) with psychotropic drugs
* pre-existing malign tumor disease
* participation in another clinical trial within the past 30 days
* pregnancy or breastfeeding

Where it's running

  • Institute for Neurorehabilitation Research, BDH-Clinic Hessich Oldendorf
    Hessisch Oldendorf, Lower Saxony, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.